Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following Transplantation
暂无分享,去创建一个
D. Briscoe | C. Woda | K. Daly | N. Jain | L. Boneschansker | T. Seto | S. Bruneau | A. Contreras | N. Kochupurakkal
[1] M. Dimopoulos,et al. VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2 , 2012, International journal of cancer.
[2] H. Bøtker,et al. Effect of Everolimus Introduction on Cardiac Allograft Vasculopathy—Results of a Randomized, Multicenter Trial , 2011, Transplantation.
[3] Lei Xu,et al. Normalization of the vasculature for treatment of cancer and other diseases. , 2011, Physiological reviews.
[4] M. Daemen,et al. Early loss of peritubular capillaries after kidney transplantation. , 2011, Journal of the American Society of Nephrology : JASN.
[5] G. Mayer. Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[6] L. Otterbein,et al. Intraoperative Administration of Inhaled Carbon Monoxide Reduces Delayed Graft Function in Kidney Allografts in Swine , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[7] K. Famulski,et al. The Molecular Phenotype of Kidney Transplants , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] P. Ganz,et al. Effect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo. , 2010, Blood.
[9] L. Nie,et al. VEGF Blockade Inhibits Lymphocyte Recruitment and Ameliorates Immune-Mediated Vascular Remodeling , 2010, Circulation research.
[10] S. Staibano,et al. Angiogenesis and lymphangiogenesis in bronchial asthma , 2010, Allergy.
[11] T. Kawabe,et al. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. , 2010, American journal of respiratory cell and molecular biology.
[12] D. Bishop,et al. TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection. , 2010, Immunotherapy.
[13] P. Halloran,et al. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection , 2010, Current opinion in organ transplantation.
[14] D. Briscoe,et al. Cutting Edge: Vascular Endothelial Growth Factor-Mediated Signaling in Human CD45RO+ CD4+ T Cells Promotes Akt and ERK Activation and Costimulates IFN-γ Production , 2009, The Journal of Immunology.
[15] T. Morisaki,et al. VEGFR2 is selectively expressed by FOXP3high CD4+ Treg , 2009, European journal of immunology.
[16] E. Reed,et al. Effect of Antibodies on Endothelium , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[17] J. Bertram,et al. Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. , 2009, The American journal of pathology.
[18] G. Jhangri,et al. Endothelial Gene Expression in Kidney Transplants with Alloantibody Indicates Antibody‐Mediated Damage Despite Lack of C4d Staining , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[19] A. Keegan,et al. Lung vascular endothelial growth factor expression induces local myeloid dendritic cell activation. , 2009, Clinical immunology.
[20] N. Ferrara. Vascular Endothelial Growth Factor , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[21] F. Schena,et al. Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial , 2009, Transplantation.
[22] D. Basile,et al. VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury. , 2008, American journal of physiology. Renal physiology.
[23] E. Meijer,et al. CD40-Induced Signaling in Human Endothelial Cells Results in mTORC2- and Akt-Dependent Expression of Vascular Endothelial Growth Factor In Vitro and In Vivo1 , 2008, The Journal of Immunology.
[24] O. Dormond,et al. mTOR-understanding the clinical effects. , 2008, Transplantation proceedings.
[25] Kohei Miyazono,et al. Snail is required for TGFβ-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells , 2008, Journal of Cell Science.
[26] J. Norman,et al. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. , 2008, Kidney international.
[27] D. Bernstein,et al. Genetic Polymorphisms Impact the Risk of Acute Rejection in Pediatric Heart Transplantation: A Multi-Institutional Study , 2008, Transplantation.
[28] T. Paavonen,et al. Vascular endothelial growth factor in chronic rat allograft nephropathy. , 2008, Transplant immunology.
[29] A. G. Betz,et al. Neuropilin-1 Expression on Regulatory T Cells Enhances Their Interactions with Dendritic Cells during Antigen Recognition , 2008, Immunity.
[30] D. Briscoe,et al. Assessing the vascular effects of early erythropoietin use in pediatric renal transplant recipients , 2008, Nature Clinical Practice Nephrology.
[31] D. Briscoe,et al. Every allograft needs a silver lining. , 2007, The Journal of clinical investigation.
[32] M. Zamora,et al. Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis. , 2007, The Journal of clinical investigation.
[33] Liang Xie,et al. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. , 2007, Cancer research.
[34] T. Rabelink,et al. Peritubular endothelium: the Achilles heel of the kidney? , 2007, Kidney international.
[35] Jordan S. Pober,et al. Evolving functions of endothelial cells in inflammation , 2007, Nature Reviews Immunology.
[36] Yuguang Jiang,et al. Acute renal allograft rejection is associated with increased levels of vascular endothelial growth factor in the urine , 2007, Nephrology.
[37] Dai Fukumura,et al. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. , 2007, Microvascular research.
[38] Kenneth P. Roos,et al. Autocrine VEGF Signaling Is Required for Vascular Homeostasis , 2007, Cell.
[39] O. Dormond,et al. The Effects of mTOR-Akt Interactions on Anti-apoptotic Signaling in Vascular Endothelial Cells* , 2007, Journal of Biological Chemistry.
[40] Xueli Yuan,et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.
[41] J. D. de Fijter,et al. New horizons in prevention and treatment of ischaemic injury to kidney transplants. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[42] P. Musiani,et al. Triggering CD40 on endothelial cells contributes to tumor growth , 2006, The Journal of experimental medicine.
[43] P. Romeo,et al. Dendritic Cells Can Turn CD4+ T Lymphocytes into Vascular Endothelial Growth Factor-Carrying Cells by Intercellular Neuropilin-1 Transfer1 , 2006, The Journal of Immunology.
[44] David W. Johnson,et al. Novel renoprotective actions of erythropoietin: New uses for an old hormone (Review Article) , 2006, Nephrology.
[45] A. Choi,et al. Protective effect of carbon monoxide in transplantation , 2006, Journal of cellular and molecular medicine.
[46] Taro Matsumoto,et al. Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis. , 2006, Journal of atherosclerosis and thrombosis.
[47] R. Mannon,et al. Therapeutic Targets in the Treatment of Allograft Fibrosis , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[48] M. Faronato,et al. Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function. , 2006, Blood.
[49] T. Rabelink,et al. Angiogenesis and endothelial cell repair in renal disease and allograft rejection. , 2006, Journal of the American Society of Nephrology : JASN.
[50] Z. Haskova,et al. Vascular Endothelial Growth Factor-Induced Signaling Pathways in Endothelial Cells That Mediate Overexpression of the Chemokine IFN-γ-Inducible Protein of 10 kDa In Vitro and In Vivo1 , 2006, The Journal of Immunology.
[51] Napoleone Ferrara,et al. Angiogenesis as a therapeutic target , 2005, Nature.
[52] H. Yoshiji,et al. Function of the Vascular Endothelial Growth Factor Receptors Flt-1 and Flk-1/KDR in the Alloimmune Response In Vivo , 2005, Transplantation.
[53] M. Shibuya,et al. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. , 2005, Clinical science.
[54] S. W. Robertson,et al. Vascular endothelial growth factor impairs the functional ability of dendritic cells through Id pathways. , 2005, Biochemical and biophysical research communications.
[55] R. Jain. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.
[56] G. Russ,et al. Early cyclosporine withdrawal from a sirolimus‐based regimen results in better renal allograft survival and renal function at 48 months after transplantation , 2005, Transplant international : official journal of the European Society for Organ Transplantation.
[57] Bart Landuyt,et al. Vascular Endothelial Growth Factor and Angiogenesis , 2004, Pharmacological Reviews.
[58] D. Hicklin,et al. Anti‐vascular endothelial growth factor receptor‐2 (Flk‐1/KDR) antibody suppresses contact hypersensitivity , 2004, Experimental dermatology.
[59] D. Briscoe,et al. TNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathy. , 2004, Transplantation.
[60] R. Homer,et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung , 2004, Nature Medicine.
[61] Hsiu‐Po Wang,et al. Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma. , 2004, Journal of biomedical science.
[62] M. Probst-Kepper,et al. Frontline: Neuropilin‐1: a surface marker of regulatory T cells (Vol. 34(3) 2004, pp 623–630, DOI 10.1002/eji.200324799) , 2004 .
[63] I. Cohen,et al. Angiogenesis-Inflammation Cross-Talk: Vascular Endothelial Growth Factor Is Secreted by Activated T Cells and Induces Th1 Polarization , 2004, The Journal of Immunology.
[64] Y. Mori,et al. Mechanism for IL-1β-mediated Neovascularization Unmasked by IL-1βKnock-out Mice(Molecular Biology, Vascular 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society) , 2004 .
[65] D. Mukhopadhyay,et al. Neuropilin-1-mediated Vascular Permeability Factor/Vascular Endothelial Growth Factor-dependent Endothelial Cell Migration* , 2003, Journal of Biological Chemistry.
[66] D. Mukhopadhyay,et al. Proinflammatory functions of vascular endothelial growth factor in alloimmunity. , 2003, The Journal of clinical investigation.
[67] A. Valujskikh,et al. Emerging roles of endothelial cells in transplant rejection. , 2003, Current opinion in immunology.
[68] P. Ganz,et al. EXPRESSION PATTERNS OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN HUMAN CARDIAC ALLOGRAFTS: ASSOCIATION WITH REJECTION , 2003, Transplantation.
[69] M. Haubitz,et al. ELEVATED NUMBERS OF CIRCULATING ENDOTHELIAL CELLS IN RENAL TRANSPLANT RECIPIENTS , 2003, Transplantation.
[70] K. Alitalo,et al. Angiopoietin-1 Protects Against the Development of Cardiac Allograft Arteriosclerosis , 2003, Circulation.
[71] P. Mathieson,et al. Steroid-sensitive nephrotic syndrome and vascular endothelial growth factor gene polymorphisms. , 2003, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[72] Sunjay Jain,et al. Sequential protocol biopsies from renal transplant recipients show an increasing expression of active TGF β , 2002, Transplant international : official journal of the European Society for Organ Transplantation.
[73] D. Briscoe,et al. Endothelial injury: cause and effect of alloimmune inflammation , 2002, Transplant infectious disease : an official journal of the Transplantation Society.
[74] J. Wood,et al. Vascular Endothelial Growth Factor Enhances Cardiac Allograft Arteriosclerosis , 2002, Circulation.
[75] Olivier Hermine,et al. A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response , 2002, Nature Immunology.
[76] M. Shibuya,et al. Vascular Endothelial Growth Factor Is Necessary in the Development of Arteriosclerosis by Recruiting/Activating Monocytes in a Rat Model of Long-Term Inhibition of Nitric Oxide Synthesis , 2002, Circulation.
[77] D. Briscoe,et al. A rendezvous before rejection: Where do T cells meet transplant antigens? , 2002, Nature Medicine.
[78] A. Krasinskas,et al. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: An alternative mechanism of allorecognition , 2002, Nature Medicine.
[79] L. Truong,et al. Role of the microvascular endothelium in progressive renal disease. , 2002, Journal of the American Society of Nephrology : JASN.
[80] D. Briscoe,et al. Angiogenesis and Allograft Rejection , 2002 .
[81] D. Mukhopadhyay,et al. Flt-1-mediated Down-regulation of Endothelial Cell Proliferation through Pertussis Toxin-sensitive G Proteins, βγ Subunits, Small GTPase CDC42, and Partly by Rac-1* , 2002, The Journal of Biological Chemistry.
[82] C. Mavroudis,et al. Serum vascular endothelial growth factor as a surveillance marker for cellular rejection in pediatric cardiac transplantation. , 2002, Transplantation.
[83] D. McDonald,et al. Angiogenesis and remodeling of airway vasculature in chronic inflammation. , 2001, American journal of respiratory and critical care medicine.
[84] D. Mukhopadhyay,et al. Vascular Permeability Factor (VPF)/Vascular Endothelial Growth Factor (VEGF) Receptor-1 Down-modulates VPF/VEGF Receptor-2-mediated Endothelial Cell Proliferation, but Not Migration, through Phosphatidylinositol 3-Kinase-dependent Pathways* , 2001, The Journal of Biological Chemistry.
[85] J. Hughes,et al. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. , 2001, Journal of the American Society of Nephrology : JASN.
[86] J. Hughes,et al. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. , 2001, Journal of the American Society of Nephrology : JASN.
[87] D. McDonald,et al. Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation. , 2001, The American journal of pathology.
[88] Janice A. Nagy,et al. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor , 2001, Nature Medicine.
[89] S. Kanazawa,et al. VEGF, basic-FGF, and TGF-β in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation , 2001, American Journal of Gastroenterology.
[90] S. Kanazawa,et al. VEGF, basic-FGF, and TGF-β in Crohn’s disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation , 2001 .
[91] D. Walsh,et al. Angiogenesis in the pathogenesis of inflammatory joint and lung diseases , 2001, Arthritis research.
[92] N. Aoike,et al. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. , 2001, The Journal of allergy and clinical immunology.
[93] L. Truong,et al. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. , 2000, Human pathology.
[94] D. Mukhopadhyay,et al. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo , 2000 .
[95] P. Ganz,et al. The role of the graft endothelium in transplant rejection: Evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection , 2000, Pediatric transplantation.
[96] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[97] S. Rafii,et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. , 2000, The Journal of clinical investigation.
[98] Sunjay Jain,et al. The role of transforming growth factor beta in chronic renal allograft nephropathy. , 2000, Transplantation.
[99] Napoleone Ferrara,et al. Clinical applications of angiogenic growth factors and their inhibitors , 1999, Nature Medicine.
[100] E. Duh,et al. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. , 1999, Diabetes.
[101] R. Jain,et al. Angiogenesis in the huPBL-SCID model of human transplant rejection. , 1999, Transplantation.
[102] Peter Shaw,et al. The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection. , 1999, Transplantation.
[103] S. Abdulla. Angiogenesis and inflammation , 1999 .
[104] R. Busse,et al. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. , 1999, Diabetes.
[105] G. Bishop,et al. Vascular endothelial growth factor expression in human chronic renal allograft rejection. , 1999, Transplantation.
[106] M Aguet,et al. VEGF is required for growth and survival in neonatal mice. , 1999, Development.
[107] F. Brasch,et al. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease. , 1999, Hepato-gastroenterology.
[108] D. Carbone,et al. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. , 1998, Blood.
[109] N. Tamura,et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. , 1998, Circulation.
[110] G. Majno. Chronic inflammation: links with angiogenesis and wound healing. , 1998, The American journal of pathology.
[111] A. Lichtman,et al. Interactions between T lymphocytes and endothelial cells in allograft rejection. , 1998, Current opinion in immunology.
[112] S. Soker,et al. Tumor Necrosis Factor-α Regulates Expression of Vascular Endothelial Growth Factor Receptor-2 and of Its Co-receptor Neuropilin-1 in Human Vascular Endothelial Cells* , 1998, The Journal of Biological Chemistry.
[113] R K Jain,et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. , 1998, The Journal of investigative dermatology.
[114] K. Plate,et al. Vascular endothelial growth factor , 1997, Journal of Neuro-Oncology.
[115] E. Abel. Clinical applications of research on angiogenesis , 1996 .
[116] M. Klagsbrun,et al. Vascular endothelial growth factor and its receptors. , 1996, Cytokine & growth factor reviews.
[117] R. Jain,et al. During angiogenesis, vascular endothelial growth factor regulate natural killer cell adhesion to tumor endothelium , 1996, Nature Medicine.
[118] G. Breier,et al. The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities , 1996, The Journal of Biological Chemistry.
[119] R. Jain,et al. Leukocyte-endothelial adhesion and angiogenesis in tumors , 1996, Cancer and Metastasis Reviews.
[120] M. Suthanthiran,et al. Intragraft TGF-β1 mRNA: A correlate of interstitial fibrosis and chronic allograft nephropathy , 1996 .
[121] A. Mantovani,et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. , 1996, Blood.
[122] Kenneth J. Hillan,et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.
[123] C. Orosz,et al. Can graft endothelial cells initiate a host anti-graft immune response? , 1996, Transplantation.
[124] W. Faulk,et al. Vascular endothelial growth factor expression in transplanted human hearts. , 1995, Transplantation.
[125] J. Stone,et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.
[126] S. Soker,et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. , 1995, Cancer research.
[127] R. Strieter,et al. THE ROLE OF CXC CHEMOKINES AS REGULATORS OF ANGIOGENESIS , 1995, Shock.
[128] Janet Rossant,et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.
[129] D. Mukhopadhyay,et al. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation , 1995, Nature.
[130] E. Manseau,et al. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. , 1995, Journal of immunology.
[131] N. Olsen,et al. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue , 1994, The Journal of experimental medicine.
[132] A. Koch,et al. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[133] P. Libby,et al. Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[134] G. Haines,et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. , 1994, Journal of immunology.
[135] E. Keshet,et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.
[136] T. Allen,et al. Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. , 1992, Journal of cell science.
[137] J. Fiddes,et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.
[138] D. Goeddel,et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.
[139] R. Auerbach,et al. Angiogenesis induction by CD-4 positive lymphocytes. , 1988, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[140] D. Koshland. Frontiers in immunology. , 1987, Science.
[141] A. Koch,et al. Induction of Neovascularization by Activated Human Monocytes , 1986, Journal of leukocyte biology.
[142] R. Auerbach,et al. Nature of the stimulus leading to lymphocyte-induced angiogenesis. , 1979, Journal of immunology.
[143] R. Auerbach,et al. Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction , 1975, The Journal of experimental medicine.
[144] A. McMahon,et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. , 2010, The American journal of pathology.
[145] R. Kalluri,et al. Conversion of vascular endothelial cells into multipotent stem-like cells , 2010, Nature Medicine.
[146] Jung‐Sik Kim,et al. Vascular endothelial growth factor-induced chemotaxis and IL-10 from T cells. , 2009, Cellular immunology.
[147] Shin,et al. Vascular Endothelial Growth Factor Is a Key Mediator in the Development of T Cell Priming and Its Polarization to Type 1 and Type 17 T Helper Cells in the Airways , 2009 .
[148] Rakesh K. Jain,et al. Taming vessels to treat cancer. , 2008, Scientific American.
[149] H. Kikutani,et al. Immune Semaphorins: Novel Features of Neural Guidance Molecules , 2008, Journal of Clinical Immunology.
[150] Atsushi Kumanogoh,et al. Semaphorins and their receptors in immune cell interactions , 2008, Nature Immunology.
[151] Z. Haskova,et al. Vascular endothelial growth factor-induced signaling pathways in endothelial cells that mediate overexpression of the chemokine IFN-gamma-inducible protein of 10 kDa in vitro and in vivo. , 2006, Journal of immunology.
[152] N. Ferrara. The role of VEGF in the regulation of physiological and pathological angiogenesis. , 2005, EXS.
[153] D. Hicklin,et al. Anti-vascular endothelial growth factor receptor-2 antibody accelerates renal disease in the NZB/W F1 murine systemic lupus erythematosus model. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[154] M. Goddard,et al. Angiogenesis occurs within the intimal proliferation that characterizes transplant coronary artery vasculopathy. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[155] M. Klagsbrun,et al. Neuropilin is a Mediator of Angiogenesis , 2004, Cancer and Metastasis Reviews.
[156] H. Matsubara,et al. Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice. , 2004, Journal of molecular and cellular cardiology.
[157] R. Geffers,et al. Frontline: Neuropilin‐1: a surface marker of regulatory T cells , 2004, European journal of immunology.
[158] P. Harden,et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. , 2002, Journal of the American Society of Nephrology : JASN.
[159] D. Mukhopadhyay,et al. Flt-1-mediated down-regulation of endothelial cell proliferation through pertussis toxin-sensitive G proteins, beta gamma subunits, small GTPase CDC42, and partly by Rac-1. , 2002, The Journal of biological chemistry.
[160] D. Mukhopadhyay,et al. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. , 2000, Blood.
[161] M. Eaman. Immune system. , 2000, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[162] M. Wilhelm,et al. Chronic rejection. , 1998, Transplantation proceedings.
[163] S. Soker,et al. Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. , 1998, The Journal of biological chemistry.
[164] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. , 1997, EXS.
[165] P. Polverini. Role of the macrophage in angiogenesis-dependent diseases. , 1997, EXS.
[166] R. Jain,et al. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. , 1996, Nature medicine.
[167] M. Suthanthiran,et al. Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy. , 1996, Kidney international.
[168] J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.
[169] D. Arenberg,et al. Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. , 1995, Biochemical and biophysical research communications.
[170] T. Allen,et al. Pericyte differentiation. , 1995, Clinical orthopaedics and related research.
[171] J. Folkman. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. , 1995, The New England journal of medicine.
[172] B. Berse,et al. Vascular Permeability Factor/endothelial Growth Factor (vpf/vegf): Accumulation and Expression in Human Synovial Fluids and Rheumatoid Synovial Tissue , 1994 .
[173] S. Wahl,et al. Inflammation and Repair , 1990 .
[174] D S Machado,et al. Transplantation immunology. , 1990, Immunology series.
[175] A. Krensky,et al. Microvascular destruction in renal transplant rejection. , 1989, Transplantation.
[176] D. Wiseman,et al. Macrophages, wound repair and angiogenesis. , 1988, Progress in clinical and biological research.
[177] D. Kamp,et al. Transforming growth factor-beta (TGF beta) is chemotactic for human monocytes and induces their expression of angiogenic activity. , 1988, Biochemical and biophysical research communications.
[178] Daniel L. Feeback,et al. Inflammation and Repair , 1987 .
[179] H. Shepard,et al. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α , 1987, Nature.
[180] R. Markwald,et al. Sturctural analysis of endocardial cytodifferentiation. , 1975, Developmental biology.
[181] U. Ekelund,et al. A proposed method of bias adjustment for meta-analyses of published observational studies , 2010, International journal of epidemiology.